MR imaging of urinary bladder cancer for T-staging: A review and a pictorial essay of diffusion-weighted imaging

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 6, 2013, Pages 1299-1309

  Takeuchi, Mitsuru ^a   Sasaki, Shigeru ^b   Naiki, Taku ^a   Kawai, Noriyasu ^a   Kohri, Kenjiro ^a   Hara, Masaki ^a   Shibamoto, Yuta ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya City University West Medical Center   (Japan)

Author keywords

bladder cancer; diffusion weighted imaging; staging

Indexed keywords

BLADDER CANCER; CANCER STAGING; DIFFUSION WEIGHTED IMAGING; FIBROSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO;

BLADDER CANCER; DIFFUSION-WEIGHTED IMAGING; STAGING;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84890120831     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24227     Document Type: Review

References (22)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y,. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007; 17: 201-204.
3. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251: 112-121.
4. Takeuchi M, Suzuki T, Sasaki S, et al. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. Acad Radiol 2012; 19: 827-833.
5. Watanabe H, Kanematsu M, Kondo H, et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol 2009; 192: 1361-1366.
6. El-Assmy A, Abou-El-Ghar ME, Mosbah A, et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009; 19: 1575-1581.
7. Urinary bladder. In:, Edge SB, Byrd DR, Compton CC, et al, editors. AJCC Cancer Staging Manual. 7th edition. New York, NY: Springer, 2010. p 497-505.
8. Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005; 184: 121-127.
9. Saito W, Amanuma M, Tanaka J, Heshiki A,. Histopathological analysis of a bladder cancer stalk observed on MRI. Magn Reson Imaging 2000; 18: 411-415.
10. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H,. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994; 193: 239-245.
11. Tanimoto A, Yuasa Y, Imai Y, et al. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 1992; 185: 741-747.
12. Hayashi N, Tochigi H, Shiraishi T, Takeda K, Kawamura J,. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 2000; 85: 32-36.
13. Koh DM, Collins DJ,. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-1635.
14. Narumi Y, Kadota T, Inoue E, et al. Bladder tumors: staging with gadolinium-enhanced oblique MR imaging. Radiology 1993; 187: 145-150.
15. Kazama T, Nasu K, Kuroki Y, Nawano S, Ito H,. Comparison of diffusion-weighted images using short inversion time inversion recovery or chemical shift selective pulse as fat suppression in patients with breast cancer. Jpn J Radiol 2009; 27: 163-167.
16. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66 (Suppl 1): 4-34.
17. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA,. Neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics 2006; 26: 553-580.
18. Cheng L, Neumann RM, Weaver AL, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 2000; 113: 275-279.
19. Quek ML, Stein JP, Clark PE, et al. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 2004; 17: 640-645.
20. Donat SM, Genega EM, Herr HW, Reuter VE,. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001; 165: 1117-1120.
21. Esrig D, Freeman JA, Elmajian DA, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996; 156: 1071-1076.
22. Pagano F, Bassi P, Ferrante GL, et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996; 155: 244-247.